top of page
Profile
Join date: Oct 3, 2024
Posts (4)
Apr 9, 2025 ∙ 2 min
Panakeia to attend and present at upcoming scientific and business conferences
Cambridge, UK, 9 April 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm...
15
0
Jan 22, 2025 ∙ 3 min
Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium
PANProfiler Colon achieved 92.69% positive and 94.05% negative agreement for MSI/dMMR detection Real-world blinded validation on 3178...
69
0
Jan 14, 2025 ∙ 3 min
Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancer
PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...
108
0
Stella Lempidaki
Editor
Admin
More actions
bottom of page